Skip to main content
Quest Diagnostics

The Occurrence of Noncoding Variants, Copy Number Variants, Mosaic Variants and Variants in Difficult-to-Sequence Genes in Over 10,000 Whole Exome Sequencing Tests

European Society of Human Genetics

ESHG 2023

Glasgow, Scotland, UK, June 10-13, 2023

Poster presentation: The Occurrence of Noncoding Variants, Copy Number Variants, Mosaic Variants and Variants in Difficult-to-Sequence Genes in Over 10,000 Whole Exome Sequencing Tests

Authors: Gall K, Hathaway J, Scocchia A, Howell V, Sluyters A, Saarinen I, Kangas-Kontio T, Kaare M, Wells K, Calvo del Castillo M, Muona M, Pietila T, Rantanen M, Gentile M, Salmenperä P, Paananen J, Myllykangas S, Koskenvuo J

Specialty: Genetics

Disclaimer: One or more of the authors of this publication were employed at the time by Blueprint Genetics, a subsidiary of Quest Diagnostics.

Related content

Publication
Opt in for secondary findings as part of diagnostic whole exome sequencing real life experience from an international diagnostic laboratory
Publication
Development and validation of a high throughput SARS-CoV-2 whole genome sequencing workflow in a clinical laboratory

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.